
Participate in this live event
Register with your My PCR account, add it to your calendar and receive automatic reminders.
Coordinators:
Speakers:
Objectives:
Join this webinar if you want to:
- Learn the use of imaging to better understand anatomy and dysfunction of the tricuspid valve in view of potential tricuspid regurgitation interventions
- Learn the use of imaging to select patients referred for tricuspid regurgitation transcatheter interventions and guide the procedures
Upcoming webinars in this series

Introducing the PCR Tricuspid Focus Group
The Focus Group is committed to fostering the establishment of tricuspid therapies, improving outcomes, and delivering sustainable clinical solutions for complex patients. Discover an overview of the new initiative’s mission and five ongoing working groups dedicated to improving the treatment of patients with tricuspid valve disease

This webinar is accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) for 1 hour of External CME credits.
Each participant should claim only those hours of credit that have actually been spent in the educational activity.
With N. Ajmone Marsan, B. Cosyns, E. Donal, D. Muraru and F. Praz
Thank you for watching the webinar
To download your certificate of attendance and get your CME credits, please complete the quick satisfaction survey now!
Access hereCoordinators:
Speakers:
Objectives:
Watch the replay of this webinar if you want to:
- Learn the use of imaging to better understand anatomy and dysfunction of the tricuspid valve in view of potential tricuspid regurgitation interventions
- Learn the use of imaging to select patients referred for tricuspid regurgitation transcatheter interventions and guide the procedures
Upcoming webinars in this series

Introducing the PCR Tricuspid Focus Group
The Focus Group is committed to fostering the establishment of tricuspid therapies, improving outcomes, and delivering sustainable clinical solutions for complex patients. Discover an overview of the new initiative’s mission and five ongoing working groups dedicated to improving the treatment of patients with tricuspid valve disease




